This is a recorded live presentation given by Thierry Wurch, PhD – Senior VP, Integrated Biologics Discovery at Evotec during the Antibody Engineering and Therapeutics Europe (AE&T) conference in Amsterdam, June 2022.
Content Summary:
![]() |
Thierry Wurch SVP, Integrated Biologics Discovery | Evotec Thierry joined Evotec in May 2022 as SVP Integrated Biologics Discovery. He has more than 22 years of expertise in the antibody R&D space primarily in Oncology and immune-oncology. Thierry held positions of growing strategic importance from head of an antibody discovery and engineering department (Pierre Fabre, 2003-2011), head of immunotherapy discovery research activities (Servier, 2011-2017) then moving to BD-oriented activities and heading external innovation for Oncology (Servier, 2017-2020 and Ipsen 2020-2022). Thierry is also Chairman of the antibody sub-committee at NC-IUPHAR, member of the Editorial board of mAbs Journal and Distinguished Advisor of The Antibody Society. |